PF-06372865 in Subjects With Photosensitive Epilepsy

Completed · Phase 2 · Has a placebo group

Conditions studied: Reflex Epilepsy, Photosensitive

In brief

PF-06372865 in subjects with photosensitive epilepsy

Key facts

Study ID

NCT02564029

Run by

Pfizer

People needed

7

Starts

2015-12-16

Expected to finish

2017-02-07

Last updated by the study team

2018-03-14

Who can join

Age: 18 and older, up to 60. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• A diagnosis and history of photoparoxysmal response on electroencephalogram (EEG) with or without a diagnosis of epilepsy for which subjects are taking up to 0 - 2 concomitant antiepileptic drugs.
• Subjects currently taking antiepileptic drug(s) to be on a stable dose for 4 weeks prior to Screening Visit.
• A minimum average standardized photosensitive range (SPR) across all screening timepoints of 4 in the most sensitive eye condition and a non-zero average in at least one other eye condition.

You may not qualify if…

• Subjects with a history of status epilepticus.
• Subjects who have experienced a generalized tonic-clonic convulsion in the past 6 months, at the time of the initial screening visit.

Where it is running

• Consultants in Epilepsy & Neurology, PLLC — Boise, Idaho, United States
• Johns Hopkins University Department of Neurology — Baltimore, Maryland, United States
• Barnes Jewish Hospital — St Louis, Missouri, United States
• Center for Advanced Medicine — St Louis, Missouri, United States
• Washington University School of Medicine — St Louis, Missouri, United States
• New York University Comprehensive Epilepsy Center — New York, New York, United States
• Clinical and Translational Research Center — Philadelphia, Pennsylvania, United States
• Hospital of the Univ of PA Pharmacy Service — Philadelphia, Pennsylvania, United States
• University of Pennsylvania — Philadelphia, Pennsylvania, United States
• Thomas Jefferson University Comprehensive Epilepsy Center — Philadelphia, Pennsylvania, United States
• Thomas Jefferson University Hospital EEG lab — Philadelphia, Pennsylvania, United States
• Thomas Jefferson University Investigational Drug Service — Philadelphia, Pennsylvania, United States
• General Clinical Research Center (GCRC) — Nashville, Tennessee, United States
• Vanderbilt University Epilepsy Clinic — Nashville, Tennessee, United States
• Vanderbilt University Hospital Pharmacy — Nashville, Tennessee, United States
• VU Department of Neurology — Nashville, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.